title: Industry meeting demands for more effective vaccines.
abstract: Swine flu aside, infectious disease is big business. Not all biopharma work is focused on rare diseases; new adjuvants and higher doses may be the answer to better flu control.
authors.forename: John
authors.initials: J
authors.lastname: Carroll